简单的“肠道重置”可能阻止使用Ozempic或Wegovy后的体重增加

* *Draft:* 研究人员报告了首批盲法、随机、假手术对照证据，证明一种名为十二指肠黏膜重塑术的手术可能提供一种安全且持久的无需持续用药维持减重的方法。 * *Refinement:* "首批...证据" sounds a bit clunky. Better: "研究人员报告了首项盲法、随机、假手术对照证据..." or "研究人员报告了首个...证据". "Procedure" here is a medical procedure, "手术" or "操作". Given it's endoscopic, "手术" or "治疗操作" fits. Let's use "手术" or "疗法". * *Polished:* 研究人员报告了首项盲法、随机、假手术对照证据，表明一种名为十二指肠黏膜重塑术的疗法可能提供一种安全且持久的途径，在无需持续用药的情况下维持减重效果。 * **Segment 2:** * *Source:* "The findings suggest it could help patients hold onto the benefits they achieved while taking drugs such as Ozempic or other GLP-1 therapies." * *Key Terms:* Ozempic (诺和泰/奥泽匹克 - usually 诺和泰 in China, but transliteration is okay if brand isn't specified, but Ozempic is well known), GLP-1 therapies (GLP-1疗法/胰高血糖素样肽-1疗法). * *Draft:* 这些发现表明，它可以帮助患者保持他们在服用Ozempic或其他GLP-1疗法时获得的益处。 * *Refinement:* "Hold onto" -> 保持/维持. "Benefits" -> 益处/疗效. * *Polished:* 研究结果表明，该疗法可以帮助患者保持其在服用Ozempic（诺和泰）或其他GLP-1疗法期间所取得的疗效。 * **Segment 3:** * *Source:* "As effective as GLP-1 medications are, many people stop taking them because of cost, side effects or simply not wanting to take a drug long-term," said lead author Shelby Sullivan, MD, director of the Endoscopic Bariatric and Metabolic Program at Dartmouth Health Weight Center and professor of medicine, Dartmouth Geisel School of Medicine. * *Key Terms:* lead author (主要作者/第一作者), Endoscopic Bariatric and Metabolic Program (内镜减重与代谢项目/计划), Dartmouth Health Weight Center (达特茅斯健康体重中心), Dartmouth Geisel School of Medicine (达特茅斯盖泽尔医学院). * *Draft:* “尽管GLP-1药物非常有效，但许多人因为费用、副作用或仅仅是不想长期服药而停止服用，”主要作者Shelby Sullivan医学博士说，她是达特茅斯健康体重中心内镜减重与代谢项目主任，也是达特茅斯盖泽尔医学院的医学教授。 * *Refinement:* Structure the title/affiliation properly. * *Polished:* “尽管GLP-1药物非常有效，但许多人因费用、副作用或仅仅是不愿长期服药而停药，”主要作者、达特茅斯健康体重中心内镜减重与代谢项目主任、达特茅斯盖泽尔医学院医学教授Shelby Sullivan医学博士表示。 * **Segment 4:** * *Source:* "But, if they stop these medications, weight regain occurs in the vast majority of patients, and the metabolic benefits are lost." * *Draft:* “但是，如果他们停止这些药物，绝大多数患者会出现体重反弹，代谢益处也会丧失。” * *Refinement:* "Weight regain" -> 体重反弹. "Metabolic benefits" -> 代谢获益. * *Polished:* “然而，如果患者停用这些药物，绝大多数人会出现体重反弹，且代谢获益也会随之消失。” * **Segment 5:** * *Source:* "Finding a treatment that allows patients to stop these medications without weight regain or loss of metabolic benefit is a huge unmet need. These findings indicate that this minimally invasive procedure may provide lasting weight-loss maintenance." * *Key Terms:* unmet need (未满足的需求), minimally invasive procedure (微创手术/微创操作). * *Draft:* “找到一种允许患者停止这些药物而不反弹或失去代谢益处的治疗方法是一个巨大的未满足需求。这些发现表明这种微创手术可能提供持久的减重维持。” * *Refinement:* "Huge unmet need" -> 巨大的未被满足的需求. * *Polished:* “寻找一种能让患者停药且不发生体重反弹或代谢获益丧失的疗法，是目前巨大的未被满足的需求。这些发现表明，这种微创疗法可能实现持久的减重维持。” * **Segment 6 (Heading):** * *Source:* "How the 'Gut Reset' Procedure Works" * *Draft:* “肠道重置”手术如何工作 * *Refinement:* "Gut Reset" -> 肠道重置. * *Polished:* “肠道重置”疗法的作用机制 * **Segment 7:** * *Source:* "Duodenal mucosal resurfacing is an investigational endoscopic treatment that uses controlled heat to remove damaged tissue from the inner lining of the duodenum, the first section of the small intestine just below the stomach." * *Key Terms:* investigational (研究性/试验性), endoscopic treatment (内镜治疗), controlled heat (受控热能/可控热能), inner lining (内壁/内膜), duodenum (十二指肠). * *Draft:* 十二指肠黏膜重塑术是一种研究性内镜治疗，使用受控热量去除十二指肠（胃正下方的小肠第一部分）内壁的受损组织。 * *Refinement:* "Remove" -> 去除/清除. * *Polished:* 十二指肠黏膜重塑术是一种试验性内镜治疗方法，利用可控热能去除十二指肠（位于胃正下方的小肠起始段）内壁的受损组织。 * **Segment 8:** * *Source:* "This process, which ablates (burns) the unhealthy mucosal layer, encourages the growth of new, healthier tissue." * *Key Terms:* ablates (消融), mucosal layer (黏膜层). * *Draft:* 这个过程消融（烧灼）不健康的黏膜层，鼓励新的、更健康的组织生长。 * *Refinement:* "Encourages" -> 促进. * *Polished:* 该过程通过消融（烧灼）不健康的黏膜层，促进新的、更健康的组织生长。 * **Segment 9:** * *Source:* "The ongoing REMAIN-1 trial is designed to test whether this renewal of the intestinal lining can trigger a lasting metabolic reset, helping the body maintain weight loss after stopping medications like semaglutide or tirzepatide." * *Key Terms:* REMAIN-1 trial (REMAIN-1试验), semaglutide (司美格鲁肽), tirzepatide (替尔泊肽). * *Draft:* 正在进行的REMAIN-1试验旨在测试这种肠内膜的更新是否能引发持久的代谢重置，帮助身体在停止司美格鲁肽或替尔泊肽等药物后维持体重减轻。 * *Refinement:* "Renewal" -> 更新/再生. "Metabolic reset" -> 代谢重置. * *Polished:* 正在进行的REMAIN-1试验旨在验证这种肠黏膜的更新能否引发持久的代谢重置，从而帮助身体在停用司美格鲁肽或替尔泊肽等药物后维持减重效果。 * **Segment 10 (Heading):** * *Source:* "Trial Results Show Less Weight Regain" * *Draft:* 试验结果显示较少的体重反弹 * *Polished:* 试验结果显示体重反弹减少 * **Segment 11:** * *Source:* "The current findings come from * *Draft:* “特别令人鼓舞的是，这种益处似乎随时间增加而不是消退，而且在剂量反应方面表现得像药物一样，”Sullivan博士说。“这让我们有信心，我们针对的是正确的生物学机制。” * *Refinement:* "Targeting the right biology" is a common phrase in medical research. "针对的是正确的生物学机制" or "针对正确的生物学靶点" works. "Biology" here refers to the underlying biological process/pathway. Let's stick to "生物学机制" or just "生物学原理". "Fade" -> "减弱" or "消退". "Dose response" -> "剂量反应". * *Polished:* “特别令人鼓舞的是，获益似乎随时间推移而增加而非减弱，且在剂量反应方面表现如药物一般，”Sullivan博士表示。“这让我们确信，我们针对的是正确的生物学机制。” * **Segment 2:** `

Safety and Recovery

` * *Draft:* 安全与恢复 * *Refinement:* In medical contexts, "Recovery" often translates to "康复" or "恢复期". "Safety" is "安全性". * *Polished:* `

安全性与康复

` * **Segment 3:** `

No serious complications were reported from either the device or the procedure. Recovery is relatively quick, with most patients returning to normal activities within about a day.

` * *Draft:* 没有报告来自设备或手术的严重并发症。恢复相对较快，大多数病人在大约一天内恢复正常活动。 * *Refinement:* "Procedure" -> "手术" or "操作" (medical procedure). "Device" -> "器械" or "设备". "Serious complications" -> "严重并发症". "Returning to normal activities" -> "恢复正常活动". * *Polished:* `

未见与器械或手术相关的严重并发症报告。康复相对迅速，大多数患者在大约一天内即可恢复正常活动。

` * **Segment 4:** `

"Other than recovering from the general anesthesia, there isn't much recovery time involved," Dr. Sullivan said. "You can be back to your daily routine in about a day. Participants could not tell if they had the sham or real procedure because there are not a lot of symptoms after the procedure."

` * *Draft:* “除了从全身麻醉中恢复，没有涉及太多恢复时间，”Sullivan博士说。“你可以在大约一天内回到日常惯例。参与者无法分辨他们做的是假手术还是真手术，因为术后没有很多症状。” * *Refinement:* "General anesthesia" -> "全身麻醉". "Daily routine" -> "日常生活". "Sham or real procedure" -> "假手术或真实手术" (sham procedure is a standard term in clinical trials). "Symptoms" -> "症状". * *Polished:* `

“除了从全身麻醉中苏醒外，基本不需要什么恢复时间，”Sullivan博士说道，“大约一天就能回归日常生活。参与者无法分辨自己接受的是假手术还是真实手术，因为术后症状很少。”

` * **Segment 5:** `

Why the Gut Is Key to Weight Regulation

` * *Draft:* 为什么肠道是体重调节的关键 * *Refinement:* "Gut" -> "肠道". "Weight Regulation" -> "体重调节". * *Polished:* `

为何肠道是体重调节的关键

` * **Segment 6:** ` ` (Keep as is, usually ignored in translation output unless HTML structure is strictly required to be preserved verbatim. The prompt asks to translate content. I will preserve the HTML tags as they appear in the source to maintain structure.) * **Segment 7:** `

The treatment targets the small intestine, where many of the hormones affected by GLP-1 drugs are produced. Over time, diets high in fat and sugar can alter the lining of the duodenum, changing how the body processes food and regulates hormones. These changes can contribute to insulin resistance and metabolic disease.

` * *Draft:* 该治疗针对小肠，那里产生许多受GLP-1药物影响的激素。随着时间的推移，高脂肪和高糖的饮食可以改变十二指肠的内衬，改变身体处理食物和调节激素的方式。这些变化可能导致胰岛素抵抗和代谢疾病。 * *Refinement:* "Targets" -> "靶向" or "针对". "Small intestine" -> "小肠". "Hormones" -> "激素". "GLP-1 drugs" -> "GLP-1类药物". "Lining of the duodenum" -> "十二指肠黏膜" or "十二指肠内壁". "Mucosal layer" is mentioned later, so "黏膜" is precise. "Insulin resistance" -> "胰岛素抵抗". "Metabolic disease" -> "代谢疾病". * *Polished:* `

该疗法靶向小肠，许多受GLP-1类药物影响的激素均产生于此。长期高脂高糖饮食会改变十二指肠黏膜，进而改变身体处理食物和调节激素的方式。这些变化可能导致胰岛素抵抗和代谢疾病。

` * **Segment 8:** `

By restoring a healthier mucosal layer, the procedure aims to reset how the body responds to food, helping stabilize metabolism at a lower body weight after stopping medications like Ozempic.

` * *Draft:* 通过恢复更健康的黏膜层，该手术旨在重置身体对食物的反应，帮助在停止像Ozempic这样的药物后稳定代谢在较低的体重。 * *Refinement:* "Mucosal layer" -> "黏膜层". "Reset" -> "重置". "Stabilize metabolism" -> "稳定代谢". "Ozempic" -> "Ozempic" (keep brand name or use 诺和泰, usually keep English or add Chinese in brackets. Since it's a specific drug name, keeping it or transliterating is fine. I will keep "Ozempic" as it is standard in professional texts or use the generic context). "Stopping medications" -> "停药". * *Polished:* `

通过恢复更健康的黏膜层，该手术旨在重置身体对食物的反应，帮助患者在停用Ozempic等药物后将代谢稳定在较低的体重水平。

` * **Segment 9:** `

What Comes Next

` * *Draft:* 接下来是什么 * *Refinement:* "What Comes Next" -> "未来展望" or "后续步骤". "未来展望" sounds more professional in a report context. * *Polished:* `

未来展望

` * **Segment 10:** `

Duodenal mucosal resurfacing is still considered investigational. The larger REMAIN-1 study includes more than 300 participants and is fully enrolled and randomized. Researchers expect topline six-month data from the pivotal cohort in early fourth quarter of 2026, followed by a planned marketing submission later that year.

` * *Draft:* 十二指肠黏膜重塑仍被认为是研究性的。更大的REMAIN-1研究包括超过300名参与者，并且已完全入组并随机化。研究人员预计在2026年第四季度初获得关键队列的六个月顶线数据，随后计划在那年晚些时候提交上市申请。 * *Refinement:* "Duodenal mucosal resurfacing" -> "十二指肠黏膜重塑术" (standard medical term). "Investigational" -> "研究性" or "处于研究阶段". "Fully enrolled and randomized" -> "已完成入组并随机化". "Topline... data" -> "顶线数据". "Pivotal cohort" -> "关键队列". "Marketing submission" -> "上市申请". * *Polished:* `

十二指肠黏膜重塑术目前仍处于研究阶段。规模更大的REMAIN-1研究纳入了300多名参与者，目前已完成入组并随机化。研究人员预计将于2026年第四季度初获得关键队列的六个月顶线数据，并计划于同年晚些时候提交上市申请。

` * **Segment 11:** `

Dr. Sullivan will present the findings from the study, "Duodenal mucosal resurfacing prevents weight regain after tirzepatide withdrawal: REMAIN-1 multicenter, randomized, double-blind, sham-controlled clinical trial -- midpoint cohort results," abstract 642, at